In honor of Molecular Therapy’s 25th anniversary, this episode is the second in a series hosted by Dr. Joseph Glorioso, Editor-in-Chief of Molecular Therapy, that will cover comprehensive reviews of critical developments in the field of gene and cell therapy over the past 25 years.  

In this episode, Dr. Glorioso will discuss the reviews, AAV vector development, back to the future, with author Sheila Mikhail; M34, Inc.; and The deLIVERed promises of gene therapy: Past, present, and future of liver-directed gene therapy; with author Dr. Mark Kay, Stanford University. 

If you enjoy this deep dive into research that is critical to the field, check out two more ASGCT events happening this fall: Advancing Cell and Gene Therapies for Cancer and Breakthroughs in Targeted In Vivo Gene Editing. During these events – in October and November, respectively – you’ll be able to hear directly from researchers about their own work related to these topics, or you can submit your own abstract for possible presentation. We hope to see you there! 

Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. www.scottbuckley.com.au

In honor of Molecular Therapy&rsquo;s 25th anniversary, this episode is the second in a series hosted by Dr. Joseph Glorioso, Editor-in-Chief of Molecular Therapy, that will cover comprehensive reviews of critical developments in the field of gene and cell therapy over the past 25 years.&nbsp;&nbsp;
In this episode, Dr. Glorioso will discuss the reviews, <a href="https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(25)00273-4?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1525001625002734%3Fshowall%3Dtrue">AAV vector development, back to the future</a>, with author Sheila Mikhail; M34, Inc.; and <a href="https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(25)00215-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1525001625002151%3Fshowall%3Dtrue">The deLIVERed promises of gene therapy: Past, present, and future of liver-directed gene therapy</a>; with author Dr. Mark Kay, Stanford University.&nbsp;
If you enjoy this deep dive into research that is critical to the field, check out two more ASGCT events happening this fall: <a href="https://www.asgct.org/events/2025-advancing-cell-and-gene-therapies-for-cancer">Advancing Cell and Gene Therapies for Cancer</a> and <a href="https://www.asgct.org/events/breakthroughs">Breakthroughs in Targeted In Vivo Gene Editing</a>. During these events &ndash; in October and November, respectively &ndash; you&rsquo;ll be able to hear directly from researchers about their own work related to these topics, or you can submit your own abstract for possible presentation. We hope to see you there!&nbsp;
Music: 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. <a href="https://www.scottbuckley.com.au/" data-cke-saved-href="https://www.scottbuckley.com.au/">www.scottbuckley.com.au</a>

The American Society of Gene & Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.

The American Society of Gene &amp; Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.

Advertisement